Michael J. Burdiek - 12 Dec 2025 Form 4 Insider Report for DocGo Inc. (DCGO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Dec 2025, 16:11:46 UTC
Prior SEC filing
14 Aug 2025
Next SEC filing
22 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jerilyn Laskie, as Attorney-in-Fact for Michael J. Burdiek

Key filing fact

Michael J. Burdiek filed Form 4 for DocGo Inc. (DCGO) on 16 Dec 2025.

Key facts

  • This page summarizes Michael J. Burdiek's Form 4 filing for DocGo Inc. (DCGO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Dec 2025, 16:11.

Change

  • Previous filing in this sequence was filed on 14 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001324293 Primary reporting owner

Burdiek Michael J

Relationship
Director
Address
C/O DOCGO INC., 685 THIRD AVENUE, 9TH FLOOR, NEW YORK
Signature
/s/ Jerilyn Laskie, as Attorney-in-Fact for Michael J. Burdiek
Signature date
16 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DCGO transaction

Common Stock

Award

Transaction value
$0
Shares
+150,000
Change %
+23%
Price
$0.000000
Shares after
791,560
Date
12 Dec 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on December 12, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .